CURE’s childhood cancers page is a go-to resource for oncology news and updates in the world of childhood cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in childhood cancers.
June 12th 2024
The Food and Drug Administration granted a traditional approval to Retevmo for adult and pediatric patients 2 years old and older with advanced or metastatic RET fusion-positive thyroid cancer.